DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

DNA binding ligands with potent antimicrobial activity against Gram-positive bacteria were further optimized by variation of the internal aromatic amino acids. This modification led to compounds with improved in vivo efficacy in lethal murine models of peritonitis (methicillin-resistant S. aureus, MRSA) and lung infection (S. pneumoniae).

Knowledge Graph

Similar Paper

DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids
Bioorganic & Medicinal Chemistry Letters 2004.0
Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors
Bioorganic & Medicinal Chemistry 2009.0
Antibacterial and Solubility Optimization of Thiomuracin A
Journal of Medicinal Chemistry 2016.0
Pentamidine congeners. 4. DNA binding affinity and anti-Pneumocystis carinii activity of butamidine analogues
Bioorganic & Medicinal Chemistry Letters 1996.0
Aryl urea analogs with broad-spectrum antibacterial activity
Bioorganic & Medicinal Chemistry Letters 2004.0
Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase
Bioorganic & Medicinal Chemistry Letters 2009.0
Structure–activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities
Bioorganic & Medicinal Chemistry Letters 2005.0
Synthesis, antimicrobial activity, attenuation of aminoglycoside resistance in MRSA, and ribosomal A-site binding of pyrene-neomycin conjugates
European Journal of Medicinal Chemistry 2019.0
Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC–MurF)
Bioorganic & Medicinal Chemistry 2014.0